Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart
- PMID: 16857549
- DOI: 10.1016/j.rapm.2005.02.011
Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart
Abstract
Background and objectives: Infusion of a lipid emulsion has been advocated for treatment of severe bupivacaine cardiac toxicity. The mechanism of lipid rescue is unknown. These studies address the possibility that lipid infusion reduces cardiac bupivacaine content in the context of cardiac toxicity.
Methods: We compared the effects of a 1% lipid emulsion with standard Krebs buffer after inducing asystole in isolated rat heart with 500 micromol/L bupivacaine. We compared times to first heart beat and recovery of 90% of baseline rate pressure product (RPP = heart rate x [left ventricular systolic pressure - left ventricular diastolic pressure]) between controls and hearts receiving 1% lipid immediately after bupivacaine. We also used minibiopsies to compare control bupivacaine tissue content with hearts getting lipid immediately after an infusion of radiolabeled bupivacaine. We then compared bupivacaine efflux from hearts with and without lipid infusion started 75 seconds after radiolabeled bupivacaine was administered.
Results: Infusion of lipid resulted in more rapid return of spontaneous contractions and full recovery of cardiac function. Average (+/- SEM) times to first beat and to 90% recovery of rate pressure product were 44.6 +/- 3.5 versus 63.8 +/- 4.3 seconds (P < .01) and 124.7 +/- 12.4 versus 219.8 +/- 25.6 seconds (P < .01) for lipid and controls, respectively. Lipid treatment resulted in more rapid loss of bupivacaine from heart tissue (P < .0016). Late lipid infusion, 75 seconds after bupivacaine infusion ended, increased the release of bupivacaine measured in effluent for the first 15-second interval compared with controls (183 vs. 121 nmol, n = 5 for both groups, P < .008).
Conclusions: Lipid emulsion speeds loss of bupivacaine from cardiac tissue while accelerating recovery from bupivacaine-induced asystole. These findings are consistent with the hypothesis that bupivacaine partitions into the emulsion and supports the concept of a "lipid sink." However, the data do not exclude other possible mechanisms of action.
Comment in
-
Clonidine in resuscitation of bupivacaine-related cardiac arrest.Reg Anesth Pain Med. 2007 May-Jun;32(3):270-1; author reply 271. doi: 10.1016/j.rapm.2007.01.002. Reg Anesth Pain Med. 2007. PMID: 17543829 No abstract available.
-
Immediate lipid emulsion therapy in the successful treatment of bupivacaine systemic toxicity.Reg Anesth Pain Med. 2009 May-Jun;34(3):276. doi: 10.1097/AAP.0b013e31819a1323. Reg Anesth Pain Med. 2009. PMID: 19436187 No abstract available.
Similar articles
-
The comparative effects of lipid, epinephrine, and their combination in the reversal of bupivacaine-induced asystole in the isolated rat heart.Anesth Analg. 2012 Apr;114(4):886-93. doi: 10.1213/ANE.0b013e3182166a0a. Epub 2011 Apr 25. Anesth Analg. 2012. PMID: 21519055
-
Lipid emulsion pretreatment has different effects on mepivacaine and bupivacaine cardiac toxicity in an isolated rat heart model.Br J Anaesth. 2014 Apr;112(4):735-41. doi: 10.1093/bja/aet353. Epub 2013 Oct 29. Br J Anaesth. 2014. PMID: 24169820
-
Lipid emulsion improves recovery from bupivacaine-induced cardiac arrest, but not from ropivacaine- or mepivacaine-induced cardiac arrest.Anesth Analg. 2009 Oct;109(4):1323-6. doi: 10.1213/ane.0b013e3181af7fb3. Anesth Analg. 2009. PMID: 19762764
-
Lipid resuscitation: a life-saving antidote for local anesthetic toxicity.Curr Pharm Biotechnol. 2011 Feb 1;12(2):313-9. doi: 10.2174/138920111794295800. Curr Pharm Biotechnol. 2011. PMID: 21050161 Review.
-
Lipid rescue resuscitation from local anaesthetic cardiac toxicity.Toxicol Rev. 2006;25(3):139-45. doi: 10.2165/00139709-200625030-00001. Toxicol Rev. 2006. PMID: 17192120 Review.
Cited by
-
Intravenous Lipid Emulsion Rescue Therapy in a Child with Carisoprodol Overdose.Cureus. 2019 Nov 27;11(11):e6250. doi: 10.7759/cureus.6250. Cureus. 2019. PMID: 31890446 Free PMC article.
-
Multi-modal contributions to detoxification of acute pharmacotoxicity by a triglyceride micro-emulsion.J Control Release. 2015 Jan 28;198:62-70. doi: 10.1016/j.jconrel.2014.11.018. Epub 2014 Dec 4. J Control Release. 2015. PMID: 25483426 Free PMC article.
-
Measurement of the efficacy of 2% lipid in reversing bupivacaine- induced asystole in isolated rat hearts.BMC Anesthesiol. 2014 Jul 30;14:60. doi: 10.1186/1471-2253-14-60. eCollection 2014. BMC Anesthesiol. 2014. PMID: 25089118 Free PMC article.
-
Fatty-acid oxidation and calcium homeostasis are involved in the rescue of bupivacaine-induced cardiotoxicity by lipid emulsion in rats.Crit Care Med. 2012 Aug;40(8):2431-7. doi: 10.1097/CCM.0b013e3182544f48. Crit Care Med. 2012. PMID: 22647409 Free PMC article.
-
Lipid emulsion for xenobiotic overdose: PRO.Br J Clin Pharmacol. 2023 Jun;89(6):1708-1718. doi: 10.1111/bcp.15620. Epub 2023 Apr 4. Br J Clin Pharmacol. 2023. PMID: 36454165 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources